The rapidly evolvable influenza A virus has caused pandemics linked to millions of deaths in the past century. Influenza A viruses are categorized by H (hemagglutinin; HA) and N (neuraminidase; NA) proteins expressed on the viral envelope surface. Analyses of past pandemics suggest that the HA gene segment comes from a nonhuman virus, which is then introduced into an immunologically na€ ıve human population with potentially devastating consequences. As a prerequisite for infection, the nonhuman HA molecules of H1-H16 viruses must be able to bind to specific sialyl receptors on the host cell surface along the human respiratory tract. Thus, additional insight into the structures of host cell glycans and how different HAs interact with different glycans might provide new insight into the mechanisms underlying sustained infection and transmission in humans. In this work, we identified the sialyl N-glycans found in normal human alveoli and characterized the influenza viruses that preferentially bound to these different structures. We also determined the amino acid changes in HA that were linked to a switch of receptor-binding preference from nonhuman to pandemic, as well as pandemic to seasonal. Our data provide insight into why seasonal viruses are associated with reduced alveolar infection and damage and suggest new considerations for designing anti-HA vaccines and drugs. The results provide a better understanding of viral tropism and pathogenesis in humans that will be important for prediction and surveillance of zoonotic, pandemic, and epidemic influenza outbreaks.
Introduction
The rapidly evolvable influenza A virus, with a genome made up of eight negative-sense single-stranded RNA segments, has never been absent from humankind since it was first identified in 1918. There have been four pandemics so far: H1N1, of unknown origin, in 1918 resulted in at least 40 million deaths; H2N2, containing three avian (H2, N2 and PB1) and five human virus gene segments, in 1957 resulted in about 2 million deaths; H3N2, containing two avian (H3 and PB1) and six human virus gene segments, in 1968 caused about 1 million deaths; and H1N1, containing two avian (PB2 and PA), five swine (H1, NP and NS from classical swine virus; N1 and M from Eurasian swine virus) and one human (PB1) virus gene segments, in 2009 resulted in at least 18 000 deaths [1] . As a result of ongoing virus-host coevolutionary selection, only H3N2/68 and H1N1/09 variants continue to cause seasonal influenza in humans at present. According to a World Health Organization report, these variants cause severe illness in an estimated 3-5 million people and about 250 000-500 000 deaths annually. The persistent threat of epizootic influenza A viruses, especially avian [2, 3] and swine [4] influenza viruses, to humans is an important caveat of the next pandemic.
Past pandemics have suggested that a pandemic virus must derive the hemagglutinin (HA) gene segment from a nonhuman virus for coding HAs carrying major viral antigens in a human population that is immunologically na€ ıve. H1-H16 viruses rely on binding of their HAs to specific sialyl receptors on the host cell surface, a prerequisite for selecting the host cells for infection. In situ detection of the virus in specimens has indicated that human influenza virus infects the nasal mucosa [5] and tracheal, bronchial, and bronchiolar epithelial cells [6] . In contrast, avian viral antigens were primarily detected in human specimens from the lower respiratory tract, alveolar epithelial cells, and alveolar macrophages [6, 7] . Determination of the structures of glycans along the human respiratory tract may allow us to find a key factor responsible for different tropisms of these viruses from different host origins and to find the requirements for host switching of nonhuman HA to pandemic HA for sustained infection and transmission in humans.
Glycan structures of human respiratory tract tissues, including tonsil, nasopharynx, bronchus, and lung tissues, were reported to have an abundance of sialyl receptors with multiple N-acetyllactosamine (LacNAc) units [8] . Here we identified N-glycan structures derived from human alveoli and found that they have a 1.40-fold (28.41%) larger number of a2,3 sialyl receptors than a2,6 sialyl receptors with a single LacNAc unit, accounting for 99.61% of the total sialyl receptors, and have one unknown sialyl linkage bound with di-LacNAc units, accounting for 0.39% of the total sialyl receptors. These sialyl glycans determine infection of influenza viruses differing in their binding preference based on the hosts from which they are isolated. It is widely accepted that avian influenza viruses, transmitted mainly through the fecal-oral route, sharebinding preference for a2,3 sialyl glycans mainly found on bird intestinal epithelial cells [9] . In contrast, classical swine, pandemic, and seasonal viruses, which are efficient in airborne transmission, predominantly bind a2,6 sialyl glycans [10] [11] [12] extensively distributed in the porcine lung [13] and human upper respiratory tract [10] . These consistent results have led us to strongly believe that switching of binding to terminal a2,6 sialic acid (Sia) is necessary for viral adaptation to humans to cause a pandemic. However, beyond the terminal Sia linkage, the roles of the LacNAc repeat, which is dominant in the portion of the human respiratory tract above alveoli [8] , in virus binding and infection remain controversial [10, 12, [14] [15] [16] [17] [18] [19] [20] [21] . Here we synthesized a2,3/ a2,6 sialylglycopolymers containing a single LacNAc repeat (short) or triple LacNAc repeats (long) and examined direct virus binding to synthetic glycopolymer-coated plates and virus-infection inhibitory activity of these synthetic glycopolymers. Our results shed new light on the roles of LacNAc length in viral receptors. The results indicated that LacNAc length may be only an accessory of avian/swine/pandemic viral receptors (However, long human receptor-binding capacity of the pandemic virus to achieve efficient human-tohuman transmission is not unnecessary), but an essential part of the seasonal viral receptor and infection. This evidence suggests that long LacNAc, which is rare in human alveoli, determines seasonal, but not pandemic, tropism and pathogenesis. Since receptorbinding preference of the viruses is determined by amino acids in HA, we determined the molecular basis of HA amino acid changes causing a shift of nonhuman to pandemic and a drift of pandemic to seasonal receptor-binding preference of influenza viruses, contributing to viral host/tissue switching. Taken together, the results presented here provide a better understanding of viral tropism and pathogenesis in humans and viral host/tissue switching that is important for prediction and surveillance of zoonotic, pandemic and epidemic influenza outbreaks in humans and for the development of effective HA-based prevention and treatment of influenza.
Results
N-linked glycans of human alveoli carry terminal a2,3/2,6Neu5Ac predominantly with a single LacNAc moiety
Sialylglycoconjugates are important host/tissue determinants of influenza virus infection. The lack of their structural analysis in human alveoli in the deepest part of the lungs functioning in exchange of carbon dioxide from blood for oxygen drove us to isolate N-glycans from proteins of normal adult lung specimens containing 85-90% alveoli. The isolated N-glycan mixture was then separated according to N-glycan charges by a diethylaminoethanol (DEAE) column, yielding neutral, mono-sialyl, di-sialyl and trisialyl, but not tetra-sialyl, glycans (Fig. 1A) . Further separation according to hydrophobicity by an octadecyl silica (ODS) column yielded N1-N17 peaks from the neutral fraction, M1-M12 peaks from the monosialyl fraction, D1-D7 peaks from the di-sialyl fraction and T1-T5 peaks from the tri-sialyl fraction ( Fig. 1B-E) . Each peak was identified by (a) comparing its elution time with the reference 2-aminopyridine (PA)-glycans, (b) co-injecting with the candidate reference PA-glycan for confirmation of the identity, (c) digesting with several glycosidases and determining the changes in elution times in comparison with the elution times of the reference PA-glycans, and (d) determining the molecular mass by using matrixassisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS). The ODS-separated peaks, N2, N9, N11, M1, M3 and D1+D1 0 , containing more than one glycan were further separated according to their molecular size by an amide column: two peaks for each of the N2, N9, M1, M3, D1+D1 0 fractions and three peaks for the N11 fraction (data not shown). The N-glycan structure present in each amide-separated peak was then identified as described above. Finally, a total of 48 N-glycans were identified including 21 neutral, 14 mono-sialyl, eight di-sialyl and five tri-sialyl glycans. Their structures corresponding to their peak numbers and elution times recorded in glucose unit (GU) values in Fig. 1 are shown in Table 1 .
Due to its low concentration, mono-sialyl glycan in ODS peak M11 was not determined completely. Its high molecular mass of 2522 Da with ODS (GU) of 18.7 suggested a structure of (Hex) 6 (HexNAc) 5 (-deoxyHex) 1 (Neu5Ac) 1 (PA) 1 , possibly carrying triantennae or multiple LacNAc units. When treated with b-galactosidase, the sample N-glycan released only one galactose, indicating that it carries di-LacNAc units on one of the sialyl biantennae, and its structure could thus be Neu5Aca(Galb1,4Glc-NAcb1,3Galb1,4GlcNAcb1,2(Galb1,4GlcNAcb1,2)) Mana1,6(Mana1,3)Manb1,4GlcNAcb1,4GlcNAc-PA (Table 1) . The major N-glycans in human alveoli are a neutral glycan present in ODS peak N5, mono-sialyl glycan in ODS peak M9 and di-sialyl glycan in ODS peak D6, accounting for 14.7%, 12.4% and 10.6%, respectively, of the total N-glycans (Table 1) . As in the case of other vertebrate N-glycans, some N-glycans derived from human alveoli exhibit a fucose residue in an a1,6 linkage to GlcNAc adjacent to asparagine in the trimannosyl (pentasaccharide) core, Mana1,6(Mana1,3)Manb1,4GlcNAcb1,4GlcNAcb1-Asn (Man 3 GlcNAc 2 Asn), shared by all N-glycans. Due to a terminal antenna that is critical to glycan-binding protein recognition, the molar ratios were calculated according to the terminal antenna and are summarized in Fig. 2 . Based on the terminal antenna, there are three neutral types consisting of (a) high mannose N-glycans (a biantennary oligosaccharide containing a bisecting GlcNAc residue), (b) GlcNAc and (c) type 2 N-acetyllactosamine (LacNAc; Galb1,4Glc-NAcb1), and four acidic types consisting of (a) 3 0 -sialyl type 2 LacNAc, (b) 3 0 -sialyl lewis X (sLe X ; Neu5Aca2,3Galb1,4(Fuca1,3)GlcNAc), (c) 6 0 -sialyl type 2 LacNAc and (d) sialyl repeated LacNAc. The amount of neutral sugars present in human alveoli is much more than the amount of acidic sugars with the proportion of 60.27 : 38.73, in which the high mannose terminus accounts for the largest amount of 38.93 mol% of the total antennae identified. The glycoproteins in human alveoli contain moderate amounts of type 2 LacNAc (18.57 mol%), 3 0 -sialyl type 2 LacNAc (22.32 mol%) and 6 0 -sialyl type 2 LacNAc (16.10 mol%). In addition, there are small amounts of a1,3 fucosylation at the third GlcNAc, resulting in 3 0 -sialyl lewis X structures for 0.17 mol% and di-LacNAc connected to the Sia terminus resulting in sialyl repeated LacNAc structures for 0.15 mol%. Only one Sia species, Neu5Ac, and two types of linkages between Neu5Ac and Gal, a2,3 and a2,6 linkages with a ratio of 22.49 : 16.10, were found in human alveolar N-glycans. Overall, almost all of the sialyl glycans in human alveoli carry a single LacNAc moiety, whereas most of the sialyl glycans in the human respiratory tree reported previously have poly LacNAc moieties [8] , implying that LacNAc length beyond a2,3/a2,6Neu5Ac may contribute to the determination of tissue tropism and pathogenicity of influenza viruses. Fig. 1 . HPLC profiles of derivatized N-glycans from normal adult alveoli. The PA-glycans were separated on an anion exchange DEAE column (A) and eluted according to their charges: neutral (peak 1), mono-(peak 2), di-(peak 4) and tri-(peak 5) sialylated glycan fractions. Since peaks 3 and 6 have no sugar, the collected peaks (fractions) 1, 2, 4 and 5 were set equal to 100% of N-glycans released from normal adult alveoli. Each fraction was then applied onto a reverse-phase ODS column (B-E), giving elution profiles according to hydrophobicity: peaks N1-17 for the neutral fraction, M1-12 for the mono-sialyl fraction, D1-7 for the di-sialyl fraction and T1-5 for the tri-sialyl fraction. A peak name with a prime, e.g. N5 0 , is an epimeric byproduct of a pyridylamination reaction. An asterisk on a peak indicates that no PA-glycan was detectable in the fraction. The corresponding structures and contents based on the peak areas are shown in Table 1 . Table 1 . Structures and ratios of N-glycans from a normal adult alveolar specimen. Peak codes correspond to the individual peaks eluted from the ODS column ( Fig. 1B-E ). Glucose unit (GU) was recorded from the elution time of each peak from the ODS column. The ratio as a percentage of each N-glycan in the specimens was calculated from each peak area derived from ODS ( Fig. 1B-E) and/or amide columns by comparison with the total N-glycan content. The ratio as pmolÁmg À1 of each N-glycan in the specimens was calculated using peak intensity on the HPLC divided by dry delipidated weight of the specimens. (Fig. 4 ). This is in agreement with glycan-binding specificity of avian influenza A/Chicken/Pennsylvania/2004 (H2N2) HA, which was previously shown to have a high level of binding to short and long a2,3 sialyl glycans with insignificant binding to a2,6 sialyl glycans [16] . In contrast, swine influenza A/swine/Tochigi/1/2008(swH1/ 08) virus and pandemic influenza A/Narita/1/09 (pdmNAH1/09) and A/California/04/09 (pdmCAH1/09) viruses did not bind to a2,3Neu5Ac-PGA but demonstrated binding specific to a2,6Neu5Ac-PGA, by which For selective recognition of long a2,6 sialyl glycans during evolution of human influenza A/H3N2 viruses, there is good agreement among different published papers [15, [19] [20] [21] . This differs from results for receptorbinding specificity of other influenza A viruses, for which different researchers have reached different conclusions, possibly due to different methodology and/or materials, including isolated virus or recombinant HA and glycan structures with or without conjugates. None of the tested viruses bound to (LacNAc) 1 -PGA or (LacNAc) 3 -PGA without Sia (data not shown), confirming that Sia is a key determinant in influenza virus attachment. Ultimately, influenza A viruses can be classified into two groups: group 1 preferential to terminal a2,3Neu5Ac, which constitutes only one subgroup for all tested avian viruses nonselective for binding to short and long receptors; and group 2 preferential to terminal a2,6Neu5Ac, which can be divided into subgroup 1 consisting of swH1/08 and pdmH1/09 viruses, which are nonselective to the length of sialyl LacNAc, and subgroup 2 consisting of pdmH3/68-derived viruses (huH3/ 08 viruses) and re-emerged H1/77-derived viruses (huH1/04 and huH1/06 viruses) selective for binding to the long sialyl receptor. The difference in a2,6-favored viruses (group (b)) in LacNAc length-binding preference was further clarified by an infection inhibition assay. Based on structures similar to physiological glycans on the host cell surface, the synthesized sialyl (LacNAc) 1, 3 glycopolymers (Fig. 3 ) could competitively prevent viral HA-glycan surface interactions according to their binding ability for viruses. As shown in Fig. 5 , it appeared that infection of swH1/08, pdmCAH1/09 and pdmNAH1/09 in AX4 cells was inhibited by either Neu5Aca2,6(LacNAc) 3 50 values against pandemic than swine virus infection imply that pandemic viruses may have higher binding avidity than swine viruses to sialyl glycans on host AX4 cells. Seasonal huKKH1/06, huYGH1/06 and hu102H3/08 infections were strongly inhibited by Neu5Aca2,6 (LacNAc) 3 -PGA with IC 50 values of 3.63, 3.84 and 0.68 lM, respectively, but they were insensitive to Neu5Aca2,6(LacNAc) 1 -PGA inhibition. These results confirm nonselectivity for LacNAc length-binding preference of swine and pandemic (early human-adapted) viruses and selectivity for long receptor-binding specificity of seasonal 29-year circulating H1 virus and 40-year circulating H3 viruses.
Long-term circulating human viruses have highly glycosylated HA heads and receptor-binding amino acid changes
To gain a better understanding of the molecular basis of receptor-binding preference of influenza A viruses, we compared HA amino acid sequences (Table S1 , Fig. S1 and Table 2 ) and structures of nonhuman and early and long-term human-adapted HAs (Figs 6 and 7). As shown in Table 2 and Fig. 7 , there are three amino acids that changed from avH3 to pdmH3/68, namely N159S, Q226L and G228S; three that changed Long-term human adapted HA: 6′Sia(LacNAc) 3 13 HAU from avH1 to pdmH1/18 (exact origin unknown but believed to be an avian virus entering and adapting in humans for a period of time before sparking the pandemic outbreak [22] ), namely T159S, E190D and/or G225D; and three that changed from swH1 to pdmH1/09, namely N145K, A219I and A227E. E190D/G225D in H1 HA and Q226L/G228S in H3 HA are well-known critical substitutions for the a2,3 to a2,6 receptor shift in HA-binding specificity [23, 24] . An undocumented mutation at position 159 may be responsible for the receptor topology shift by alteration of the 190-helix conformation for optimal contact with sugars bending from the Neu5Aca2,6Gal-motif, but further proof is needed. An H5 virus has never so far caused a pandemic, but they continue to occasionally infect humans, highlighting the need for surveillance. Previous mutagenesis studies indicated that triple mutations in the H5 receptor-binding site (RBS), namely Q196R/Q226L/G228S [25] , N158D/ N224K/Q226L [26] or N186K/Q226L/G228S [27] , exhibited a decrease in a2,3 binding and increase in a2,6 binding. In the present study, none of the tested H5 viruses had the above amino acid changes (Table 2) , this being consistent with the finding that they have an a2,3-binding preference (Fig. 4) . Different from an avian-to-human host switch, an swH1/08-to-human host switch does not require a2,3 to a2,6 binding HA mutations. Actually, swH1/08 HA originated from the classical swine lineage believed to be introduced from pdmH1/18 HA [28] . Compared to pdmH1/18 RBS (Table 2 and Fig. 7 ), swH1/08 HA appeared to retain D190/X225 conferring a2,6 binding preference but had changes in amino acids at the positions of 155 (T155V), 145 (S145N), 159 (S159N), 186 (P186S) and 189 (T189A). Further investigation is needed to determine how important these amino acid changes are for swine adaptation. In 2009, the swH1 virus invaded the human population and rapidly caused the 2009 pandemic. Two bulkier A219I and A227E substitutions could fill the H1-binding pocket, clashing with the extra hydroxyl group on the N-acetyl group of Neu5Gc, while the other N145K substitution provides direct interaction with the Neu5Ac C4 hydroxyl group (Fig. 6) . Acquisition of these three substitutions may therefore be an early adaptation of swH1 HA to decrease binding to Neu5Gc present in the porcine respiratory tract [13] but absent in human hosts [29] . However, further investigation is needed to clarify the effects of these three substitutions in swH1 on virus-binding preference for Sia species. T155I/V substitution has been reported to increase Neu5Gc-binding affinity [30] . Table 2 shows that dkH5, mlH5 and swH1 HAs contain I/V155 related to the presence of Neu5Gc in the duck intestine [9] and swine respiratory tract [13] . Finding V155 in pdmH1/09 HA but not in other pandemics (Table inset in Fig. 7 ) confirms that the pandemic of 2009 is the only pandemic in which HA was retrieved from a swine-adapted HA. Up to now (2017), V155 in the RBS hollow remains unchanged, and monitoring the acquisition of V155T should therefore be continued to understand viral evolution. Different from a Sia/linkage shift of nonhuman-topandemic HAs new to human immunity that are exposed to new host receptors, a dual-to-long sialyl drift of pandemic-to-seasonal HAs seems to occur due to HA exposure to the host's acquired immune response (ambient noise) co-evolved with the virus. The virus must adjust the tuning sites (antigenic sites) some overlapping with the RBS and HA head glycosylation sites, over time to confer mutation-selection balance between viral immune evasion and viral infectivity. As shown in Table 2 and Fig. 7 1&3  1&3  ND  1&3  ND  ND  ND  ND  ND  ND  3  3  ND  ND  ND  ND  ND  ND  ND  ND  3  3  ND  1&3  ND  1&3  1&3  ND  ND   163  165   135a   Table 2 . Changes in RBS amino acids (H3 numbering) and number of glycosylation sites (NXS/T sequon with X denoting any amino acid except Pro) on the HA head. Glycosylation sites are shown in warm pink, and amino acids forming the basin surface area in Fig. 7 are coloured in salmon. Amino acids changing from avH1/H3 to pdmH1/H3 are coloured in cyan; those changing from pdmH1/H3 to seasonal H1/H3 are shown in pale green and in dark green if they changed during circulation in humans; those changing from pdmH1/18 to swH1/08 are shown in blue; and those changing from swH1/08 to pdmH1/09 are shown in light blue. Amino acid residues in the RBS with a straight underline, wavy underline and no underline indicate residues forming secondary structures of a loop, an alpha-helix and a b-sheet, respectively. The left columns show summarized results from Fig. 4 for virus-binding preference. ND, not determined.
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and H1/77 re-emerged came to have an abundance of amino acid substitutions around the receptor-binding pocket and an increased number of HA head glycosylation sites, from one up to four sites for H1/77-derived HAs and from two up to six sites for pdmH3/ 68-derived HAs. A previous study [31] showed that D225N mutation, but not S193F mutation, in H3/04 HA caused markedly reduced short receptor binding as a result of loss of hydrogen-bond interaction with 2-Gal. However, N225D reversion with K158N, F159Y and N189K becoming dominant since 2014 requires further study. Although the effects of hostderived glycans on the HA head on HA binding depend on several factors including the position, composition and size of the glycans, glycan addition on the HA head is typically accompanied by reduced binding to short receptors [32] but not to long receptors. Taken together, the drifting away from short receptor binding of seasonal viruses may have resulted from the combined effects of RBS amino acid drift and increase in HA head glycans.
Discussion
Avian and pandemic viruses typically cause diffuse alveolar damage that is usually more severe than that from seasonal viruses, for which alveolar infection is rarely reported [7, 33] , and this challenges us to investigate human alveolar glycans that are resistant to seasonal viruses. All of the identified 21 neutral and 27 acidic human alveolar N-glycans are on the common Man 3 GlcNAc 2 Asn core. Some human alveolar N-glycans contain a core a1,6-fucose commonly found in vertebrates but not an a1,3-fucose core typically found in invertebrates. Another modification at the core detected in some human alveolar N-glycans is a bisecting GlcNAc residue commonly found in N-glycans derived from humans [8] , quails and chickens [34] but not found in swine [13, 35] . Effects of the core modifications on viral HA-glycan binding specificity require further study.
Terminal sequences of N-glycans are crucially important determinants for the intrinsic and extrinsic recognition that mediate cellular, symbiotic and pathogenic processes. Terminal human alveolar N-glycans consist of a 60.27 : 38.73 ratio of neutral : acidic chains. About 39% of the neutral antennae are unsubstituted terminal mannose (Man 5-9 GlcNAc 2 ) with 14.7% being Man 5 GlcNAc 2 . The remaining neutral antennae are composed of 18.57% type 2 LacNAc (Galb1,4GlcNAc) and 2.77% GlcNAcb1,2Mana1 structures, commonly found in vertebrate hosts. Gala1,3Galb1 found in porcine [13, 35] and ferret [36] respiratory tracts and N,N 0 -diacetyllactosamine (LacdiNAc; GalNAcb1,4GlcNAcb1) found in the ferret respiratory tract [36] were not detected in the human respiratory tract [8] including human alveoli. These findings indicate differential regulation of the glycosyltransferase response in the respiratory tracts of different animals.
Terminal Sia antennae on glycoconjugates are required for obligate host Sia-dependent H1-H16 virus infection but not for H17 and H18 viruses having HAs with negatively charged S/T136D and nonhydroxylbearing Y98F substitutions [37] . However, most mammalian cells exhibit both of two common Sia species, Pandemic H1/09: 6′Sia(LacNAc) 1, 3 
H1/08
An erect bipedal humans
Vertical air way A quadrupedal pig Fig. 7 . Schematic surface diagram of the RBS and glycosylated HA heads. Each monomer of the HA homo-trimer in marine, pink and lime was glycosylated as shown in blue, warm pink and lime green sticks, respectively, using GLYCOPROT. The RBS bound with a sialyl receptor (Sia in magenta, Gal in bright orange, GlcNAc in blue, Glc in red) was zoomed out from one monomer. Amino acid changes are coloured as described in Table 2 . The number of glycosylation sites on each monomer is indicated. PDB identification codes are shown in parentheses. Using PYMOL, amino acid residues in the 1rvt (swH1/30) RBS were mutated to corresponding residues found in swH1/08 RBS, 3ube (pdmH1/09) residues were mutated to H1/16 RBS and 2wrg (pdmH1/18) residues were mutated to H1/06 RBS. The inset table shows the origins of genes of historical pandemics.
Neu5Ac and Neu5Gc, normal adult human cells, including human alveoli, express only Neu5Ac due to the lack of a Neu5Ac-to-Neu5Gc hydroxylase [29] . Influenza A virus can drift to increased or decreasedbinding avidity to specific Sia species by changing HA amino acid(s) in response to selective pressure of the host glycan surface. Early human-adapted swine-origin pdmH1/09 viruses have a three-amino-acid change in the swH1 RBS, with bulkier A219I and A227E substitutions, which could narrow the HA-binding pocket leading to clashes with the extra hydroxyl group of Neu5Gc, and a positively charged N145K substitutions which directly interacts with Neu5Ac. However, V155, associated with HAs that have fully adapted to Neu5Gc-containing hosts [30] , is still present in H1/17-derived pdmH1/09 HA. If the H1-derived pdmH1/09 virus continues to circulate in humans lacking Neu5Gc synthesis, it may finally acquire V155T due to obviating the need for binding to Neu5Gc receptors.
In addition to Sia species, the asialo portion, including glycosidic linkage types and inner sugar residues varying among animal species, contributes to influenza virus-binding specificity. Human-and swine-adapted viruses with D190/D225 in H1 and L226/S228 in H3 HAs prefer the a2,6 sialyl linkage, which is dominant in the human tracheal epithelium [10] and porcine lung [13] . Avian viruses, including duck and poultry viruses with E190/G225 in H1, Q226/G228 in H3 and Q226/ G228 H5 HAs, favor the a2,3 sialyl linkage, which is mainly found in the duck and chicken intestinal epithelium [9, 34] . Both a2,3 and a2,6 linkages were detected in human alveolar N-glycans with a higher molar ratio of a2,3 over a2, 6 (22.49 : 16.10) . These findings could explain why diffuse alveolar damage is the most common manifestation of a2,3-preferring avian virus infection in humans. On the other hand, the expression of the a2,6 linkage is more dominant than that of the a2,3 linkage in the lower part (lung) of the porcine respiratory tract [13] , which is a typical site of swine-adapted virus infection [38] . However, the main virus replication sites in the horizontal airway of quadrupedal pigs and in the vertical airway of bipedal humans are rich in a2,6 linkages, and both swineadapted and human-adapted HAs acquire strong a2,6 binding. Both porcine and human respiratory tracts are susceptible to avian, swine and human virus infection [2, 3, 39] . Taken together, human alveoli, which serve for passing air in and out of the bloodstream, could be a platform for avian influenza virus setting and the human respiratory tract could be a potential vessel for the generation of a pandemic virus.
The second sugar from the nonreducing end of sialyl glycoconjugates that can be found in nature and is recognized by influenza A viruses might be Gal, GalNAc or GlcNAc, which form the terminal disaccharide motifs of Neu5Aca2,3/6Gal, Neu5Aca2,3/6GalNAc and Neu5Aca2,6GlcNAc, respectively [40] . Neither Neu5Aca2,6/3GalNAc, which is present in ferret respiratory tissue [36] , nor Neu5Aca2,6GlcNAc, which is present in milk N-glycans [41] , was detected in human alveolar N-glycans. Only Neu5Aca2,3/6Gal, which is commonly found in tissues susceptible to influenza virus infection including human [8, 10] , porcine [13] and ferret [36] respiratory tissues and avian intestinal tissues [34] , was detected in human alveolar N-glycans. The 2-Gal may be branched, typically with GalNAc via a b1,4 linkage such as an Sda epitope (Neu5Aca2,3(GalNAcb1,4)Galb1,4GlcNAc) in ferret respiratory tissues [36] . However, such a branched sialyl glycan, which has not been detected in the human respiratory tract including the alveoli, is not well recognized by influenza virus hemagglutinins [42] .
The third sugar of sialylglycoconjugates could be a nonacetylated (Glc) or acetylated (GalNAc or GlcNAc) residue linking with the 2-Gal as follows: lactose (Galb1,4Glc), N-acetyllactosamine type 1 (Le c ; Galb1,3GlcNAc), type 2 (Galb1,4GlcNAc) or type 3 (Galb1,3GalNAc) motif. In general, influenza A viruses have a higher binding specificity to sialyl LacNAc commonly found on epithelial cells than respective sialyl-lactose found on cell membrane GM3 ganglioside (Neu5Aca2,3Galb1,4Glcb1,1 0 ceramide) and in milk. Among the three types, sialyl LacNAc type 3 structures are restricted to core 1 of O-glycoproteins found in the human nasopharynx, bronchus and lung [8] and to GM1b ganglioside (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4Glcb1,1 0 -ceramide) found in rat ascites hepatoma [42] . Sialyl LacNAc types 1 and 2 can be found in O-and Nglycoproteins as well as on glycolipids. Whereas type 1 structures are mainly present in the gastrointestinal tract, the latter are ubiquitous throughout the animal body and are possibly fucosylated and/or sulfated at the third sugar GlcNAc (3-GlcNAc), affecting viral HA-receptor-binding activity. No sulfation or fucosylation at 3-GlcNAc in ferret respiratory glycans [36] or in quail and chicken colon glycans [34] has been identified so far. Sulfated sialyl glycans have been found in embryonated egg cells [43] and the porcine lung (sulfate position not known [35] ). Fucosylation at 3-GlcNAc has been observed in the chicken larynx and trachea [44] , the human lung (not in sialylated form) [8] and human alveoli in this study. Only 0.17% of branched SLe x was detected in human alveolar glycans, this being a potential receptor of tracheal chicken-derived H5N2 LPAI virus [44] . The remaining 22.32% of human alveolar 3 0 -sialyl glycans were all unbranched Neu5Aca2,3Galb1,4GlcNAc. These findings indicated that the inner parts of sialyl glycans are highly variable in different animals/tissues and might contribute to viral host range restriction. However, some avian viruses, such as chicken HPAI H5N1 virus and wild bird-duck-poultry reassortant H7N9 virus, have been occasionally isolated from several animal species, including pigs [39] and humans [2, 3] , possibly due to flexibility of their HA pockets for varied 3 0 -sialyl structures, lowering viral host-range restriction.
Potential binding of the shallow pockets of humanadapted HAs to sugar residues beyond the sialyl LacNAc trisaccharide and the finding of sialyl LacNAc repeats in human bronchial epithelial cells [10] give rise to the question of whether the LacNAc repeat structure plays a role in viral host-range restriction and viral pathogenicity. The LacNAc repeat has so far been detected only in ferret [36] and human respiratory tracts [8] . We found only one Neu5Ac(LacNAc) 2 structure, this being 0.15% of total human alveolar Nglycans, whereas sialyl poly-LacNAc structures detected in the human upper respiratory tract were more abundant and there were various numbers of LacNAc units (1-10 units) [8, 10] . This finding could be a factor in explaining why long-term circulating human viruses, which prefer 6 0 -sialyl poly-LacNAc receptors (probably as a result of deepening of the shallow RBS pocket due to the presence of four to six sites of HA head glycans surrounding the RBS pocket and as a result of reduction in interactions of the RBS pocket with short receptors due to antigenic changes in the RBS pocket), have rarely been reported for human alveolar infection but are strongly associated with tracheobronchitis [6, 33] . Also, this finding could explain why pdmH1/09 viruses, which bind 6 0 -sialyl glycans with either single-or triple-LacNAc repeats, have broad tissue tropism dominant in the tracheobronchial tree in uncomplicated cases (http://who.int/ csr/resources/publications/swineflu/clinical_manageme nt_h1n1.pdf) and in the lung parenchyma in fatal cases [33] . Thus, it is not surprising that early seasonal viruses circulating for < 20 years in humans have often been detected in pigs [45, 46] , which express predominantly short 6 0 -sialyl receptors [13, 35] . The swineadapted H1/08 virus was also found to bind both short and long 6 0 -sialyl glycans, and swine-to-human transmission events are not uncommon [4] . Additionally, we found that avian viruses can efficiently bind both short and long 3 0 -sialyl receptors. These findings suggest that LacNAc length in sialyl glycans may not be a human host barrier for nonhuman virus infections.
Once adapted to selectively bind the long sialyl receptors, the virus might have less capacity to attach in different tissues or animal species having only short sialyl receptors. However, the recent unexpected finding that human seasonal H3N2/10-11 viruses may have been introduced into pigs and evolved to become swine H3N2/12v and H3N1/14v viruses [47] suggests that (a) long sialyl LacNAc glycans might be present in pigs in a small amount that is undetectable by current techniques, (b) structures similar to sialyl polyLacNAc, such as Neu5Aca2,3(6)Galb1,4GlcNAcb1, 3Galb1,4Glc-in the ganglioside lacto-series, that are able to bind to influenza A viruses [10] may be present in pigs, and (c) high viral load and/or high density of sialyl glycans on the host cell surface could bring them close to each other, resulting in attractive interactions between terminal negative sialyl glycans and the compatible basic HA pocket, while HA head glycans might be flexible and bend, allowing viral HA-short sialyl glycan attachment. The latter possibility is supported by the previous finding that compared with pdmH1/09 virus, a high viral load was needed for seasonal H3N2/04 virus binding to the same amount of 6 0 -sialyl LacNAc-lipo PGA coated on the plate and a high concentration of 6 0 -sialyl LacNAc-lipo PGA was needed for inhibition of H3N2 hemagglutination and infection [48] .
In conclusion, understanding virus-host coevolution will lead to precision control of influenza A viruses, which can fly even without wings. Human alveoli contain short a2,3 (22.49%), a2,6 (16.10%) and a few long (0.15%) Neu5Ac-LacNAc N-glycans that might be the landing platform of avian viruses (a2,3 short and long preference) and swine and early humanadapted viruses (a2,6 short and long preference) for acquisition of binding preference to a2,6Neu5Ac with an umbrella-like topology by changing only a few amino acids in the RBS. Significant reduction of H1N1/06 (29-year circulation) and near abolition of H3N2/08 (40-year circulation) viruses with marked RBS antigenic changes and increased HA head glycosylation sites in short-receptor binding could be a factor explaining why long-term circulating viruses have reduced alveolar infection. Overall, our results indicate the possibility of nonhuman viral adaptation and/or reassortment in the human respiratory tract and show that influenza A viruses share-binding preference for long, not short, sialyl receptors, which should be a consideration for vaccine or drug development.
Materials and methods
Human alveoli
Three 5 mm 3 blocks of tissues from a 48-year-old male patient with lung adenocarcinoma were acquired from OriGene Technologies (Rockville, MD, USA), and the tissues were pathologist-verified by the company to be 100% normal lung tissues with 85-90% alveoli, 5% bronchioles and 5-10% fibrovascular tissues.
Isolation of N-glycans from human alveoli
The tissue was cleaned with cold phosphate-buffered saline (PBS; pH 7.4) and was homogenized in the same buffer by shear force in a Dounce glass homogenizer (Iwaki, Tokyo, Japan). The resulting homogenate was centrifuged at 58 000 g for 10 min at 4°C. The pellet (membrane fraction) was then resuspended (washed) in PBS and recentrifuged. After two washes, the pellet was dried by lyophilization. The membrane fraction was delipidated by incubation with 90% acetone for 1 h at À80°C. The lipid was removed by centrifugation at 110 000 g for 20 min at 4°C. The pellet was resuspended in 90% acetone and recentrifuged to remove all remaining lipid. The delipidated membrane was lyophilized (10 mg dry, defatted weight) and used as a glycoprotein source for isolation of N-glycans by the typical chemical method, hydrazinolysis, under previously described conditions [49] with minor modifications. In brief, the lyophilized glycoproteins were treated with anhydrous hydrazine (100 lL hydrazineÁmg À1 glycoprotein) for 10 h at 100°C. After removal of hydrazine by azeotropic distillation with toluene, the released N-glycans were N-acetylated by incubation with saturated sodium bicarbonate/acetic anhydride (25 : 1) solution at 4°C for 20 min and for another 30 min at ambient temperature. The N-acetylated glycans were purified by a cationexchange mini-column and dried by evaporation.
Identification of N-glycan structures
The reducing ends of the released N-glycans were labeled with the fluorescent reagent PA under previously described conditions [50] . The mixture of purified PA-glycans was separated on the basis of their charges on an anion exchange HPLC column (TSKgel DEAE-5PW column; 7.5 mm i.d. 9 75 mm; Tosoh, Tokyo, Japan) at 30°C with a flow rate of 1 mLÁmin À1 using a linear gradient of 100% solvent A (aqueous ammonia, pH 9.0) and 0% solvent B (500 mM ammonium acetate, pH 9.0) for 8 min, increasing to 12% solvent B for 14 min, then 40% solvent B for 5 min and to 100% solvent B for 1 min before returning to 0% solvent B for 27 min. PA fluorescence was monitored at an excitation wavelength of 310 nm and an emission wavelength of 380 nm. The collected fractions were evaporated to dryness, and fractions with the same charges were further separated on the basis of their hydrophobicity on a reverse-phase HPLC column (Shim-pack HRC-ODS column; 6.0 mm i.d. 9 150 mm; Shimadzu, Kyoto, Japan , and the elution time of each peak was recorded as a GU value. Identification of sample PA-glycan structures was based on GU and mass values in comparison to reference PA-glycans in the GALAXY database (http://www.glycoanal ysis.info/galaxy2/ENG/systemin1.jsp). The sample PA-glycan structures were confirmed by co-chromatography with reference PA-glycans. If there was no agreement with any of the reference PA-glycans, the sample PA-glycans were sequentially trimmed until they were identical to known references with one or more exoglycosidases.
Synthesis of sialoglycopolymers
Sialoglycopolymers used in this study were synthesized in three steps as described previously [51] . In brief, the first step was synthesis of linear (LacNAc) n b-pAP oligosaccharides (n being the number of repeating units) in a 35 mL reaction mixture containing 150 mM of Tris/HCl buffer, pH 6.8, 82 mg of MnCl 2 cofactor and 0.8 mL of 1% (w/v) NaN 3 preservative reagent, LacNAcb-p-nitrophenyl (pNP) acceptor substrate, 1.03 mmol of a UDP-GlcNAc donor substrate and 340 mU of b1,3-N-acetylglucosaminyltransferase (b3GnT). The reaction mixture was incubated for 2 days at 37°C to allow b3GnT to transfer GlcNAc from the UDP-GlcNAc donor to the LacNAcb-pNP acceptor. Then 1.03 mmol of UDP-Gal donor substrate and 2 U of b1,4-galactosyltransferase (b4GalT) were added and the mixture was further incubated for 6 days at 37°C, resulting in Galb1,4GlcNAcb1,3LacNAcb-pNP ((LacNAc) 2 b-pNP) products. After centrifugation, the synthesized oligosaccharides in the supernatant were isolated by size-exclusion chromatography with a Toyopearl HW-40S column (Tosoh), purified through a Bio-Gel P2 desalting column and lyophilized to give (LacNAc) 2 b-pNP. To synthesize (LacNAc) 3 b-pNP, the synthesized (LacNAc) 2 b-pNP was used as an acceptor substrate and conjugated to GlcNAc and Gal by b3GnT and b4GalT, respectively, in the reactions described above. Then 150 mg of each (LacNAc) n bpNP was converted to (LacNAc) n b-pAP by stirring in 30 mL of methanol containing 300 mg of ammonium formate as an amino ammonia donor and 30 mg of palladium on carbon as a catalyst at room temperature for 20 min or until complete conversion as determined by HPLC analysis. After removal of the palladium on carbon, using a Celite filter, the desired compounds in the resultant filtrate were further purified by a Chromatorex-ODS DM 1020T column (Fuji Silysia Chemical Ltd, Kasugai, Aichi, Japan), concentrated and lyophilized to obtain (LacNAc) n b-pAP powder.
In the second step, amino functional groups on the (LacNAc) n b-pAP oligosaccharides were coupled with carboxyl groups of aPGA, which was activated under the condition of constant stirring at room temperature for 15 min with benzotriazol-1-yloxy-tris(dimethylamino)-phosphonium hexafluorophosphate (a coupling agent) in the presence of 1-hydroxybenzotriazole hydrate (an additive for reducing racemization), at room temperature overnight. The products were purified using a Sephadex G-25M PD-10 column (Amersham Biosciences, Piscataway, NJ, USA), dialysed against distilled water, and lyophilized to give poly[(LacNAc) 1,3 b-pAP-]aPGA.
In the third step, sialic acid was enzymatically connected to poly[(LacNAc) 1 Direct viral HA-receptor-binding assay using viral NA-based detection
Direct binding of viral HAs to specific glycopolymers was performed as described previously [53] . In brief, fresh serial 2-fold dilutions from 0 to 5 lM (100 lL/well) of each glycopolymer in PBS, pH 7.2-7.4, were covalently immobilized onto the surface of a 96-well plate (Costar Universal-BIND Surface plate, Sigma-Aldrich) by exposure to UV light at 254 nm for 5 min. After the glycopolymer-coated plate had been washed with PBS three times and air dried, 50 lL of virus solution diluted in 0.1% Tween 20 in PBS (PBST) to 20 hemagglutination units (HAUs; tested in 0.5% turkey erythrocytes; 13 HAUs for A/Aichi/28/04 (H1N1)) was added to each well and incubated on ice for 2 h with gentle shaking. Following five washes with PBST, the glycopolymer-bound virus particles were detected quantitatively by measuring their viral NA enzyme activity. Measurement of NA activity of the bound viruses was performed in 50 lL of a reaction mixture containing 40 lM of 2 0 -(4-methylumbelliferyl)a-D-N-acetylneuraminic acid (MUNeu5Ac; TRC Inc., Toronto, Ontario, Canada) substrate in 10 mM sodium acetate buffer with CaCl 2 and MgCl 2 , pH 6.0, and 0.5% BSA. The reaction was performed at 37°C for 1 h and was terminated by mixing 25 lL of the reaction solution with 100 lL of 100 mM Na 2 CO 3 / NaHCO 3 buffer, pH 10.6, in a black flat-bottomed plate (Corning, Lowell, MA, USA). Fluorescence intensities of the 4-methylumbelliferyl (MU) products relative to viruses bound to the glycopolymers were measured at 355 nm excitation and 460 nm emission. It appeared that fluorescence intensities in the wells containing glycopolymers without Sia residues, (LacNAc) 1,3 -PGA, were similar to the intensities in the wells without glycopolymers. The measured fluorescence intensity representative of the level of virus binding to the glycopolymer was thus plotted as a function of the concentration of Sia present in the corresponding glycopolymer.
Competitive inhibition of virus binding by virus yield reduction assay in cell culture
Glycopolymers similar to receptors preferentially bound by influenza viruses could bind to the viruses competitively with the receptors on the host cell surface, resulting in lower virus infection. The assay was performed as a general method for influenza virus infection inhibition [48] . In brief, influenza virus with a multiplicity of infection of 0.06 plaque-forming units/cell in serum-free MEM containing 4 lgÁmL À1 acetylated trypsin was preincubated with an equal volume of 0-100 lM of each glycopolymer in serumfree MEM at 4°C for 1 h. A 100 lL aliquot of each virusglycopolymer mixture was overlaid onto MDCK cells in a 96-well plate and incubated in a CO 2 incubator for 24 h at 37°C. The virus infection was terminated by fixing the infected cells with methanol for 1 min. Viral nucleoproteins (NPs) expressed in the infected cells were detected by incubation with a first antibody, anti-NP mouse IgG (4E6), and a secondary antibody, b-galactosidase-labeled anti-mouse IgG (Calbiochem, San Diego, CA, USA), for 45 min each at room temperature and were quantified by incubation with a 4-methylumbelliferyl b-D-galactoside (MU-Gal; Wako, Osaka, Japan) substrate solution for another 45 min at 37°C, allowing b-galactosidase to release MU. The released fluorophore MU was measured at excitation of 355 nm and emission of 460 nm. The number of virusexpressing NPs was calculated as a percentage by comparing fluorescence intensities in wells without glycopolymers (set to 100% virus infection) and then plotted versus the concentration of Sia present in the corresponding glycopolymer (log-10 scale) using nonlinear regression analysis in PRISM software (GraphPad Software, La Jolla, CA, USA).
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